# Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis Patients

> **NCT02065713** · PHASE3 · COMPLETED · sponsor: **Instituto de Medicina Molecular João Lobo Antunes** · enrollment: 44 (actual)

## Conditions studied

- Psoriatic Arthritis

## Interventions

- **DRUG:** Golimumab
- **DRUG:** Methotrexate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02065713
- **Lead sponsor:** Instituto de Medicina Molecular João Lobo Antunes
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2020-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02065713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02065713, "Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02065713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*